Please keep comments to the company facts and development such as the hiring of full time scientists in Jan-Feb, multiple abstracts as well as oral presentations accepted at international scientific gatherings (did not happen before on any scale near 2015), new scientific board members who are specialists in the areas of RGBP product development, one new board member who is a head at one of the few nationally recognized Cancer Centers now working with RGBP to develop dCellVax for glioma as well as providing testing and data for general dCellVax IND approval, CRL (GLP) entity providing all the testing for the data to be submitted for HemaX IND approval to be completed within next 2 weeks (never happened before in company history to have such level of outside, independent lab expertise to move product line forward), several new patents and other IP purchased or filed in 2015.
I may have missed a few points, but hopefully those new to RGBP (following company less than one year) can get the idea from the facts that this is not "the same 'ol company" we've followed in the past.
Market Data 
Markets 
AI
